Literature DB >> 16078110

Cerebellopontine angle paraganglioma - report of a case and review of literature.

Prabal Deb1, Mehar Chand Sharma, Shailesh Gaikwad, Aditya Gupta, Veer Singh Mehta, Chitra Sarkar.   

Abstract

Majority of the cerebellopontine angle (CPA) tumors are acoustic neuromas, while bulk of the non-acoustic tumors are formed by meningiomas and epidermoid cysts. Primary paraganglioma is a rare tumor in this location, with only two such cases having been reported in the literature, till date. Recently, a case has been described wherein a paraganglioma was apparently arising as a primary lesion in the cerebellar hemisphere. We report another case of an intracranial paraganglioma of the CPA in a 40-year-old female, which did not have any vascular attachment but had focal cerebellar extension.

Entities:  

Mesh:

Year:  2005        PMID: 16078110     DOI: 10.1007/s11060-004-5952-0

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  24 in total

Review 1.  Intracerebral paraganglioma.

Authors:  T Reithmeier; H Gumprecht; A Stölzle; C B Lumenta
Journal:  Acta Neurochir (Wien)       Date:  2000       Impact factor: 2.216

2.  Diagnosis and management of paragangliomas of the skull base.

Authors:  C G Jackson; P F Harris; M E Glasscock; M Fritsch; E Dimitrov; G D Johnson; D S Poe
Journal:  Am J Surg       Date:  1990-04       Impact factor: 2.565

Review 3.  From the archives of the AFIP. Paragangliomas of the head and neck: radiologic-pathologic correlation. Armed Forces Institute of Pathology.

Authors:  A B Rao; K K Koeller; C F Adair
Journal:  Radiographics       Date:  1999 Nov-Dec       Impact factor: 5.333

4.  Paraganglioma of the pituitary fossa: diagnosis and management.

Authors:  K Salame; G E Ouaknine; J Yossipov; S Rochkind
Journal:  J Neurooncol       Date:  2001-08       Impact factor: 4.130

Review 5.  Cauda equina paraganglioma: a review.

Authors:  George C Miliaras; Athanassios P Kyritsis; Konstantinos S Polyzoidis
Journal:  J Neurooncol       Date:  2003-11       Impact factor: 4.130

6.  Mediastinal paraganglioma: a surgical experience.

Authors:  M F Herrera; J A van Heerden; F J Puga; M J Hogan; J A Carney
Journal:  Ann Thorac Surg       Date:  1993-11       Impact factor: 4.330

7.  Cerebello-pontine angle paraganglioma simulating an acoustic neurinoma.

Authors:  Z A Jamjoom; S Sadiq; T Malabary
Journal:  Br J Neurosurg       Date:  1991       Impact factor: 1.596

8.  Paragangliomas of the neck.

Authors:  G B Bishop; M M Urist; T el Gammal; G E Peters; W A Maddox
Journal:  Arch Surg       Date:  1992-12

9.  Symptomatic cerebellar metastasis and late local recurrence of a cauda equina paraganglioma. Case report.

Authors:  K N Strommer; S Brandner; A C Sarioglu; U Sure; Y Yonekawa
Journal:  J Neurosurg       Date:  1995-07       Impact factor: 5.115

10.  Cerebellopontine angle paraganglioma.

Authors:  Nicolas Guevara; André Chays; Michel Bruzzo; Renaud Meller; Christine Fatou-Balansard; Jacques Magnan
Journal:  Otol Neurotol       Date:  2003-05       Impact factor: 2.311

View more
  3 in total

Review 1.  Imaging of cerebellopontine angle lesions: an update. Part 2: intra-axial lesions, skull base lesions that may invade the CPA region, and non-enhancing extra-axial lesions.

Authors:  Fabrice Bonneville; Julien Savatovsky; Jacques Chiras
Journal:  Eur Radiol       Date:  2007-06-14       Impact factor: 5.315

2.  Sinonasal paraganglioma: a case report.

Authors:  Ayotunde J Fasunla; Titus S Ibekwe; Olushola A Afolabi; Paul A Onakoya; Olayiwola A Oluwasola; Olabiyi G Ogun; Adewunmi O Adeoye; Onyekwere G Nwaorgu
Journal:  Oral Maxillofac Surg       Date:  2008-07

3.  Primary Cerebellar Neuroendocrine Tumors: Chimeras or Real Entities? A Case Report with a 6-Year Follow-Up.

Authors:  Claudio Vernieri; Daniela Femia; Sara Pusceddu; Carlo Capella; Juan Rosai; Giuseppina Calareso; Laura Concas; Natalie Prinzi; Giuseppe Lo Russo; Filippo de Braud; Roberto Buzzoni
Journal:  Case Rep Oncol       Date:  2016-08-17
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.